摘要
肠外营养是临床所有科室营养治疗的重要手段之一,可以改善患者营养摄入和营养状况,改善患者临床结局。肠外营养是风险最大的用药方式之一,涉及患者群体广泛,处方组分多样,配比复杂等问题,不同专业医生对适应证把握、处方组分、输注途径选择等方面存在许多差异,可能导致肠外营养相关用药的安全性问题,使用不当甚至会对患者造成伤害或死亡。为提高中国临床医生使用肠外营养制剂的安全性,最大限度地提高肠外营养应用的临床获益,中国抗癌协会肿瘤营养专业委员会、中华医学会肠外肠内营养学分会组织专家制订了本共识。内容主要根据我国营养诊疗现状、国内外发表的循证医学证据,结合临床、药学、营养、护理等领域的专家经验和意见,采用牛津循证医学中心(Oxford Center for Evidence‐Based Medicine,OCEBM)分级标准,围绕肠外营养的适应证、配制、输注途径选择、并发症处理等方面制订推荐意见,旨在为国内肠外营养临床应用的规范化和标准化提供依据。
Parenteral nutrition(PN)serves as an important therapeutic modality in all clinical departments,which can improve the nutritional intake and nutritional status of patients,and improve the clinical outcome of patients.PN is one of the most risky forms of medication.That is used for a variety of indications,has diverse prescription components and infusion approaches.There are many differences between doctors of different specialties in the grasp of indications,prescription components,infusion route selection and other aspects,which may lead to safety PN problems,even to death.To improve the safety of parenteral nutrition for Chinese clinicians and maximize the clinical benefits of parenteral nutrition.Chinese Society of Nutritional Oncology,Chinese Society of Parenteral and Enteral Nutrition organized experts to formulate this consensus.This consensus according to Chinese nutrition diagnosis and treatment status,published evidence,combined with clinical,pharmaceutical,nutrition,nursing and other fields of expertise.These consensus recommendations are based on practices and Oxford Center for Evidence⁃based Medicine(OCEBM)grading standards that are generally accepted to minimize errors with PN therapy,categorized in the areas of PN prescribing,compounding,infusion route selection,and complications administration.
出处
《肿瘤代谢与营养电子杂志》
2021年第5期495-502,共8页
Electronic Journal of Metabolism and Nutrition of Cancer
基金
国家重大疾病多学科合作诊疗能力建设项目(2019YLFW)。
关键词
肠外营养
安全性
专家共识
Parenteral nutrition
Safety
Expert consensus
